Natus Medical Incorporated (BABY)
BABY Price and Sentiment
BABY Latest news
Is Natus Medical Stock a Buy?
2020-05-31 06:53What should investors think of this infant care and neurology specialist?
Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q1 2020 Results - Earnings Call Transcript
2020-05-02 09:43Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q1 2020 Results - Earnings Call Transcript
Natus Medical (NTUS) Lags Q1 Earnings and Revenue Estimates
2020-04-30 18:55Natus Medical (NTUS) delivered earnings and revenue surprises of -81.82% and -0.11%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Natus Medical (NTUS) Earnings Expected to Grow: Should You Buy?
2020-04-23 12:32Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors
2020-03-20 08:00PLEASANTON, Calif., March 20, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced the appointment of Ilan Daskal, current Chief Financial Officer & Executive Vice President of Bio-RAD Laboratories, to its board of directors and audit committee effective March 19, 2020. The Company will also nominate Mr. Daskal at its 2020 Annual Meeting of Stockholders.
Here's Why NuVasive, Exelixis, and Natus Medical Fell Today
2020-03-12 17:40The healthcare companies couldn't sidestep the COVID-19 slump.
Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2019 Results - Earnings Call Transcript
2019-10-26 09:29Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2019 Results - Earnings Call Transcript
Natus Medical (NTUS) Misses Q3 Earnings and Revenue Estimates
2019-10-24 19:05Natus Medical (NTUS) delivered earnings and revenue surprises of -5.26% and -1.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Natus Medical Announces Third Quarter 2019 Financial Results
2019-10-24 16:05PLEASANTON, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced financial results for the three and nine months ended September 30, 2019.
Natus Medical (BABY) Q2 Earnings and Revenues Top Estimates
2019-07-25 20:05Natus Medical (BABY) delivered earnings and revenue surprises of 13.33% and 2.19%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?